Condition: Dementia Alzheimer Type · Dementia Associated With Cerebrovascular Disease · Sponsor: Jasmohan Bajaj
Using a new formulation of rifaximin, a non-absorbable antibiotic, to test if it can affect microbes in the gut of patients with dementia favorably.
This description comes directly from the study's public registry record.
Jasmohan S Bajaj, MD · 804-675-5802 · jasmohan.bajaj@vcuhealth.org
Haley Obolewicz, RN · 804-675-5705 · haley.obolewicz@va.gov
Always discuss trial participation with your own doctor first.
| Richmond VA Medical Center | Richmond, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06718686